Equity Overview
Price & Market Data
Price: $1.02
Daily Change: $0.00 / 0.00%
Daily Range: $0.822 - $1.10
Market Cap: $5,124,624
Daily Volume: 450,686
Performance Metrics
1 Week: 12.09%
1 Month: -22.73%
3 Months: -80.67%
6 Months: -88.12%
1 Year: -95.79%
YTD: -80.67%
Details
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.